Page last updated: 2024-08-21

sulfanilylurea and framycetin

sulfanilylurea has been researched along with framycetin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
DECOURTJUNIOR, C	1

Other Studies

2 other study(ies) available for sulfanilylurea and framycetin

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
[EXPERIENCES WITH AN ASSOCIATION OF FORMO-PHTHALYL-SULFANILYLUREA AND NEOMYCIN IN INTESTINAL THERAPY]. Hospital (Rio de Janeiro, Brazil), 1964, Volume: 65 Topics: Child; Diarrhea; Diarrhea, Infantile; Humans; Infant; Intestines; Neomycin; Salmonella Infections; Sulfanilamide; Sulfanilamides; Sulfonamides	1964

Article

Year

FDA-approved drug labeling for the study of drug-induced liver injury.

Drug discovery today, 2011, Volume: 16, Issue:15-16

Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011

[EXPERIENCES WITH AN ASSOCIATION OF FORMO-PHTHALYL-SULFANILYLUREA AND NEOMYCIN IN INTESTINAL THERAPY].

Hospital (Rio de Janeiro, Brazil), 1964, Volume: 65

Topics: Child; Diarrhea; Diarrhea, Infantile; Humans; Infant; Intestines; Neomycin; Salmonella Infections; Sulfanilamide; Sulfanilamides; Sulfonamides

1964